Home
Photo of Thomas Schön

Thomas Schön

Professor

My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.

News

vaccination.

SEK 15 million for research into Covid-19 vaccination

A research project coordinated by LiU has been awarded more than SEK 15 million by the Swedish Research Council to evaluate vaccination against Covid-19.

Publications

Latest publications in LiU DiVA

2024

V. N. Dahl, A. Burke, A. Floe, J. Bruchfeld, Thomas Schön, C. M. Wejse, A. B. Andersen, E. Svensson, J. Van Ingen, L. Davies Forsman (2024) Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria The International Journal of Tuberculosis and Lung Disease, Vol. 28, p. 212-213 Continue to DOI
F. Rudolf, E. Abate, B. Moges, V. F. Gomes, A. M. Mendes, A. Sifna, H. Fekadu, S. Bizuneh, C. Wejse, Thomas Schön (2024) A structured 2-week follow-up visit in the cascade of care for TB increases case detection The International Journal of Tuberculosis and Lung Disease, Vol. 28, p. 148-153 Continue to DOI
Paolo Miotto, Daniela M. Cirillo, Thomas Schön, Claudio U. Koeser (2024) The exceptions that prove the rule-a historical view of bedaquiline susceptibility Genome Medicine, Vol. 16, Article 39 Continue to DOI
Tobias Damgaard, Hanna Woksepp, Lars Brudin, Jonas Bonnedahl, Elisabet I. Nielsen, Thomas Schön, Anita Hällgren (2024) Estimated glomerular filtration rate as a tool for early identification of patients with insufficient exposure to beta-lactam antibiotics in intensive care units Infectious Diseases Continue to DOI
Sainan Wang, Lina Davies Forsman, Chunhua Xu, Haoyue Zhang, Yue Zhu, Ge Shao, Shanshan Wang, Jiayi Cao, Haiyan Xiong, Katarina Niward, Thomas Schön, Judith Bruchfeld, Limei Zhu, Jan-Willem Alffenaar, Yi Hu (2024) Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment International Journal of Infectious Diseases, Vol. 140, p. 62-69 Continue to DOI

Research

A doctor looks at X-rays.

Individualised diagnosis and treatment of tuberculosis

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

Organisation

Teaser image for the division II at BKV.

Division of Inflammation and Infection (II)

The Division of Inflammation and Infection (II) includes clinical subject areas such as Immunology, Rheumatology, Pathology and Microbiology.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags